Literature DB >> 24608078

Chemotherapy for Generalized Infantile Myofibromatosis With Visceral Involvement.

Susan Y Wu1, Timothy L McCavit, Kevin Cederberg, Rene L Galindo, Patrick J Leavey.   

Abstract

Infantile myofibromatosis (IM) is most commonly limited to cutaneous lesions that resolve spontaneously. However, generalized IM with visceral involvement, which has a reported mortality rate as high as 73%, has been successfully treated with a combination of methotrexate and vinblastine. Here we report the further efficacy of low-dose methotrexate and vinblastine in 2 pediatric patients with IM and visceral involvement and review the literature describing chemotherapy for these patients.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 24608078     DOI: 10.1097/MPH.0000000000000132

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  2 in total

1.  Novel PDGFRB rearrangement in multifocal infantile myofibromatosis is tumorigenic and sensitive to imatinib.

Authors:  Mohammed Hassan; Erin Butler; Raphael Wilson; Angshumoy Roy; Yanbin Zheng; Priscilla Liem; Dinesh Rakheja; Dean Pavlick; Lauren L Young; Mark Rosenzweig; Rachel Erlich; Siraj M Ali; Patrick J Leavey; D Williams Parsons; Stephen X Skapek; Theodore W Laetsch
Journal:  Cold Spring Harb Mol Case Stud       Date:  2019-10-23

2.  Aggressive infantile myofibromatosis with intestinal involvement.

Authors:  Tristan Römer; Norbert Wagner; Till Braunschweig; Robert Meyer; Miriam Elbracht; Udo Kontny; Olga Moser
Journal:  Mol Cell Pediatr       Date:  2021-06-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.